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This paper charts the almost ten years of history of OECD's work on nanosafety, during which the pro-
gramme of the OECD on the Testing and Assessment of Manufactured Nanomaterials covered the testing
of eleven nanomaterials for about 59 end-points addressing physicalechemical properties, mammalian
and environmental toxicity, environmental fate and material safety. An overview of the materials tested,
the test methods applied and the discussions regarding the applicability of the OECD test guidelines,
which are recognised methods for regulatory testing of chemicals, are given. The results indicate that
many existing OECD test guidelines are suitable for nanomaterials and consequently, hazard data
collected using such guidelines will fall under OECD's system of Mutual Acceptance of Data (MAD) which
is a legally binding instrument to facilitate the international acceptance of information for the regulatory
safety assessment of chemicals. At the same time, some OECD test guidelines and guidance documents
need to be adapted to address nanomaterials while new test guidelines and guidance documents may be
needed to address endpoints that are more relevant to nanomaterials. This paper presents examples of
areas where test guidelines or guidance for nanomaterials are under development.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Context and background
In the past 15 years, signiﬁcant efforts have been directed to-
wards understanding nanomaterials regarding properties, appli-
cations and safety aspects, as well as identifying any speciﬁc needs
for regulation. These issues and progress in addressing them have
been monitored by policy makers (SCENIHR, 2006; SCENIHR,
2007a; SCENIHR, 2007b; SCENIHR, 2009; European Commission,
2012) and also supported by for example the USA National Nano-
technology Initiative at http://www.nano.gov/you/environmental-
health-safety.1
In 2006 the OECD Working Party on Manufactured Nano-
materials was established to provide a global forum for nano-safety(K. Rasmussen), phil.sayre@
y 2015.
Inc. This is an open access article udiscussion, also in a regulatory context. It is a subsidiary body of the
OECD Chemicals Committee with more than 40 years' experience
leading a global programme promoting the understanding of
environment, health and safety aspects of chemicals (see links
http://www.oecd.org/chemicalsafety/andhttp://www.oecd.org/
environment/40yearschemicals). Box 1 gives an overview of the
areas of work addressed by the WPMN (see link http://www.oecd.
org/science/nanosafety/).
In 2011 Morris et al. (Morris et al., 2011) identiﬁed the OECD as
one of the key bodies to address nanotechnology governance is-
sues, achieved mainly through the WPMN, but other groups also
contribute such as the OECD National Co-ordinators of the Test
Guidelines Programme (see link http://www.oecd.org/env/
testguidelines).
The OECD agreement of Mutual Acceptance of Data in the
Assessment of Chemicals (OECD, 1981) (see link http://www.oecd.
org/env/ehs/mutualacceptanceofdatamad.htm), is an essential
component for international harmonisation of approaches to
chemical safety through regulatory recognition of these testnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Abbreviations
AAS Atomic absorption spectroscopy
AFFFF Asymmetric ﬂow ﬁeld ﬂow fractionation
AFM Atomic force microscopy
BET Brunauer-Emmett-Teller
BJH Barrett-Joyner-Halenda method
CLS Centrifugal liquid sedimentation
CNT Carbon nanotube
Cyto B Cytochalasin B
DCFH-DA Dichloro-dihydro-ﬂuorescein diacetate assay
DI De-ionised (water)
DLS Dynamic light scattering
DOSY NMR Diffusion ordered spectroscopy nuclear magnetic
resonance
DSC Differential scanning calorimetry
DTA Differential thermal analysis
EDX Energy dispersive X-ray
ELS Electrophoretic light scattering
EPR Electron paramagnetic resonance
GD Guidance document
HREM High resolution electron microscopy
HDD Hydrodynamic diameter
ICP Inductively coupled plasma
JRC European Commission's Joint Research Centre
LAL Limulus amebocyte lysate assay
LDH lactate dehydrogenase
Lit. Data from literature
MAD Mutual Acceptance of Data
MWCNT Multi-walled carbon nanotube
n/a not applicable
NM nanomaterial
OECD Organization for Economic Co-operation and
Development
ORP Oxidation, reduction potential
POM Polarizing optical microscopy
RBA Rose bengal adsorption method
ROS Reactive oxygen species
SAXS Small angle X-ray scattering
SDR SensorDish reader
SEM Scanning electron microscopy
SMPS Scanning mobility particle sizer™ (SMPS™)
spectrometer analysis
SWCNT Single-walled carbon nanotube
TEM Transmission electron microscopy
TG Test guideline
TGA Thermo-gravimetric analysis
TGP Test Guidelines Programme
ToF-SIMS Time-of-ﬂight secondary ion mass spectrometry
USAXS Ultra small angle X-ray scattering
UVevis Ultra violet-visible
WPMN Working Party on Manufactured Nanomaterials
WNT Working group of the national co-ordinators for the
OECD test guidelines programme
XDC X-ray disc centrifuge
XPS X-ray photoelectron spectroscopy
XRD X-ray diffraction
XRF X-ray ﬂuorescence
XTT 2,3-bis[2-Methoxy-4-nitro-5-sulfophenyl]- 2H-
tetrazolium-5-carboxyanilide
Box 1
Areas of work within the WPMN.
a) Testing and Assessment.
This has included the testing of selected nanomaterials for
physicalechemical properties, and human health and
environmental safety endpoints, using appropriate testing
methods to generate data and assess the need for the
development of new test guidelines, the updating of exist-
ing guidelines, or supplementary guidance that will allow
the use of existing or new guidelines. The aim is to ensure
that adequate means are available to identify possible
hazards posed by nanomaterials, while promoting the
development of alternative test methods for nano-toxicity
testing.
b) Promoting international co-operation on Risk Assess-
ment and Regulatory Programmes.
c) Identifying and developing guidance on Exposure Mea-
surement and Exposure.
d) Promoting the Environmentally Sustainable Use of
Nanotechnology.
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according to OECD test guidelines, which are test methods for
regulatory testing of chemicals, in countries adhering to MAD.
Accordingly, an important task under the WPMN is to ensure that
OECD test guidelines are applicable to nanomaterials, thus fallingunder MAD. OECD test guidelines are developed in the OECD test
guidelines programme, and agreed TGs are published by the OECD
at the link http://www.oecd.org/chemicalsafety/testing/
oecdguidelinesforthetestingofchemicals.htm. Guidance docu-
ments on testing do not fall under MAD but nevertheless reﬂect an
agreement on best available procedures.
The OECD test guidelines programme ensures the development
and relevant updating of TGs for the regulatory hazard testing of
chemicals through a consensus process in the OECDWNT, building
on knowledge from research and as well as regulatory requisites,
such as relevance and reproducibility. The OECD test guidelines are
developed for chemicals in general and are thus broadly applicable,
but the individual test guidelines may not be applicable to all
chemicals. Usually, recognised limitations in the area of application
is stated in the test guidelines.
In parallel with the work in the OECDWPMN, research projects,
for example projects under the European Union's 7th Framework
programme, have contributed research results to the understand-
ing of testing of nanomaterials and their properties, providing
additional insights that also contribute knowledge to develop OECD
guidance for the testing of nanomaterials.
This paper provides an overview of the activities and initial
outcomes of the OECD work on the Testing and Assessment of
Manufactured Nanomaterials, which was formally completed in
2013, and it especially focussed on understanding the adequacy of
the applied test guidelines. In the following, the terms Manufac-
tured Nanomaterials and Nanomaterials are used interchangeably.
2. The WPMN Testing and Assessment Programme
The aim of the WPMN Testing and Assessment Programme was
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subsequent analysis of the methods applied, to obtain information
contributing to nanomaterial-relevant updates of OECD test
guidelines and/or guidance documents for testing and risk assess-
ment. Each material was tested by a group of so-called sponsors,
who decided on the test methods to apply to their material. To help
and guide the sponsors, a guidance manual for the testing of
manufactured nanomaterials for OECD's Sponsorship programme
was developed (OECD, 2010). The outcomes of the Testing and
Assessment Programme includes exploratory testing of eleven
nanomaterials, as indicated in Table 1, for about 59 end-points
concerning physicalechemical properties, mammalian and envi-
ronmental toxicity, environmental fate and material safety, as
indicated in Table 2. In addition to the nanoform(s), a non-nano
form was tested for TiO2, CeO2 and ZnO. The datasets were of an
exploratory nature and without pre-deﬁned regulatory conse-
quences. The following sections present the information available
by June 2014.
The information on the endpoints was generated using current
OECD TGs, sometimes with ad-hoc adaptations, or other methods.
Regulatory data generation for traditional chemicals applies testing
strategies that can integrate non-animal and animal testing to
assess environmental and health safety. There is considerable in-
terest in exploratory research into alternative methods and their
potential application as part of an integrated testing strategy for
nanomaterials.
The six groups of end-points investigated in the Testing and
Assessment Programme, as indicated in Table 2, are similar to the
end-points for hazard assessment of chemicals, with the exception
of physical-chemical data, which are particular to characterising
nanomaterials. The information pertaining to Group A is descrip-
tive, and for Group F testing may not be needed as the materials
investigated are not likely to be ﬂammable, explosive or reactive;
Groups A and F are not further discussed here.
The same lot and batch of nanomaterial are used for testing of all
end-points thus ensuring that physical-chemical data, toxicology
data and environmental data can be compared. The Joint Research
Centre established the JRC Nanomaterials Repository for Repre-
sentative Nanomaterials. It provided samples of 8 of the nano-
materials tested in the test programme.
The Testing Programme was ﬁnalised in 2013, and the raw data
is becoming publicly available from the OECD since June 2015 at
http://www.oecd.org/chemicalsafety/nanosafety/testing-Table 1
Nanomaterials for which provided data is generated in the WPMN Testing Programme.
Chemical name of material Name of principal nanomaterial(s) test
C60 Fullerenes Nanom Purple
Single walled carbon nanotubes (SWCNT) Nikkiso SWCNT,
Super growth
Multi walled carbon nanotubes (MWCNT) Nikkiso MWCNT,
Graphicstrength C100,
Nanocyl NC7000
Silver Citrate capped silver nanoparticles. AB
Silver powder. NAMATECH Co. Ltd., Ko
Silver powder. Daedeok Science, Korea
Silver powder. SigmaeAldrich, USA
Gold NM-330
Titanium dioxide (TiO2) P 25 (NM-105)
Cerium dioxide (CeO2) NM-211 and NM-212
Zinc oxide (ZnO) NM-110, NM-111 and NM-112
Silicon dioxide (SiO2) NM-200
Dendrimers PAMAM dendrimers:
G3-PAMAM-(NH2)32 and
G4-PAMAM–(NH2)64
Nanoclay NM-600programme-manufactured-nanomaterials.htm. The initial process
of extracting information from the Testing Programme, collecting
the research experiences, analysing the testing outcomes, and
evaluating the resulting regulatory needs was carried out through
expert meetings on i) PhysicaleChemical Properties of Manufac-
tured Nanomaterials and Test Guidelines (2013) (OECD, 2014a), ii)
Nanomaterials PhysicaleChemical Parameters: Measurements and
Methods (2014); iii) Environmental Fate & Eco-Toxicology (2013)
(OECD, 2014b; Kühnel and Nickel, 2014); iv) Inhalation Toxicity
Testing for Nanomaterials (2011) (OECD, 2012a); v) Genotoxicity of
Manufactured Nanomaterials (2013) (OECD, 2014c); vi) Tox-
icokinetics of Nanomaterials (2014) and vii) Categorization of
Manufactured Nanomaterials (2014). An expert meeting on Read
Across of Data and Categories for Manufactured Nanomaterials is
planned for 2016. For ii), vi) and vii) the OECD publication proce-
dure is underway. Each report presents a summary of the meeting
including the objectives and the agenda; recommendations
including proposals for modiﬁcation of, or new, OECD Test Guide-
lines; synopsis of the presentations and the discussions; as well as a
list of participants.3. Sample preparation and dispersion media
An issue raised consistently when testing nanomaterials, both
within theWPMN and in the scientiﬁc literature, is the sample (test
item) preparation and dispersion in appropriate media. It is rec-
ognised that possible hazards associated with nanomaterials may
be affected by, for example, shape, size and surface area, because
these parameters affect both the mode of action and toxicokinetics
of particles (absorption, distribution, and excretion).
Test item preparation and dispersion (including stability) in
appropriate media is a critical issue, since many of the nano-
materials are insoluble or sparingly soluble in water and other
media used in (eco)toxicological tests. Moreover, their phys-
icalechemical properties as well as (eco)toxicological effects are
highly inﬂuenced by the interactions with the bio-physical-
chemical surroundings in these media. Thus, sample characterisa-
tion should be performed for a number of the different stages of
testing nanomaterials. The testing stages may include powder and/
or dispersion forms depending on the end-point and/or the stage
tested, and the actual material tested (the test item) has undergone
a critical process of preparation that needs to be controlled,
consistent, relevant, reliable and robust.ed Name of alternate nanomaterial(s) tested
e
e
Mitsui MWNT-7
Baytubes
Hanwa CM100
C Nanotech Co. Ltd., Korea
rea
NM-300K, rent a scientist, GmbH, Germany
e
NM-101, NM-102, NM-103, NM-104
e
e
NM-201, NM-202, NM-203, NM-204, Korean SiO2
e
e
Table 2
Groups of Endpoints agreed by the WPMN for the testing of Representative Manufactured Nanomaterials.
A. Nanomaterial Information/Identiﬁcation C. Environmental fate
1 Nano material name 27 Dispersion stability in water
2 CAS number 28 Biotic degradability
3 Structural formula/molecular structure 29 - Ready biodegradability
4 Composition of NM being tested (incl. degree of purity, known impurities or additives) 30 - Simulation testing on ultimate degradation in surface water
5 Basic Morphology 31 - Soil simulation testing
6 Description of surface chemistry (e.g. coating or modiﬁcation) 32 - Sediment simulation testing
7 Major commercial uses 33 - Sewage treatment simulation testing
8 Known catalytic activity 34 Identiﬁcation of degradation product(s)
9 Method of production (e.g. precipitation, gas phase) 35 Further testing of degradation product(s) as required
B. Physical-chemical properties and material characterization 36 Abiotic degradability and fate
10 Agglomeration/aggregation 37 - Hydrolysis, for surface modiﬁed nanomaterials
11 Water solubility 38 Adsorption- desorption
12 Crystalline phase 39 Adsorption to soil or sediment
13 Dustiness 40 Bioaccumulation potential
14 Crystallite size 41 Bioaccumulation in sediment
15 Representative TEM picture(s) D. Environmental toxicology
16 Particle size distribution 42 Effects on pelagic species (short/long term)
17 Speciﬁc surface area 43 Effects on sediment species (short/long term)
18 Zeta potential (surface charge) 44 Effects on soil species (short/long term)
19 Surface chemistry (where appropriate) 45 Effect on terrestrial species
20 Photo-catalytic activity 46 Effect on micro-organisms
21 Pour density 47 Other relevant information
22 Porosity E. Mammalian toxicology
23 Octanol-water partition coefﬁcient, where relevant 48 Pharmacokinetics (ADME)
24 Redox potential 49 Acute Toxicity
25 Radical formation 50 Repeated dose toxicity
26 Other relevant information (where available) IF AVAILABLE
51 Chronic toxicity
F. Material safety 52 Reproductive toxicity
57 Flammability 53 Developmental toxicity
58 Explosivity 54 Genetic toxicity
59 Incompatibility 55 Experience with human exposure
56 Other relevant test data
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and Dosimetry (OECD, 2012b) is considered a milestone in the
development of guidance for adequately addressing hazard testing
of nanomaterials, as indicated for instance in the OECD Council
Recommendation (OECD, 2013). This guidance document refers
and applies to water insoluble manufactured nanomaterials, as it
was considered unlikely that soluble nanomaterials would need a
sample preparation different from what is applied to chemicals in
general. An extensive effort has been undertaken outside the OECD
to classify NMs into different subclasses, see for example: http://
www.codata.org/uploads/Uniform_Description_System_
Nanomaterials-Published-v01-15-02-01.pdfhttp://www.codata.
org/uploads/Uniform_Description_System_Nanomaterials-
Published-v01-15-02-01.pdf. Consulting such a classiﬁcation sys-
tem to identify which sub-class the nanomaterial about to be tested
belongs to, could facilitate the sample preparation and dosing
step(s).
It should be noted that the classical dose metrics used to
describe doses (dosimetry), e.g. milligram test substance per kilo-
gram test animal, may not be the most suitable for nanomaterials
(SCENIHR, 2006). Since publication of the Guidance Document on
Sample Preparation and Dosimetry a number of protocols have
emerged (NIST, link http://www.nist.gov/mml/np-measurement-
protocols.cfm, PROSPEcT, link http://www.nanotechia.org/sites/
default/ﬁles/ﬁles/PROSPECT_Dispersion_Protocol.pdf, Nano-
genotox, link http://www.nanogenotox.eu/ﬁles/PDF/Deliverables/
nanogenotox%20deliverable%203_wp4_%20dispersion%
20protocol.pdf; and ENPRA (Jacobsen et al., 2010)) and recom-
mendations (Tantra et al., 2015) aiming to become reference for
future studies. Also the dispersion of nanomaterials for testing has
been further studied, and a review of several aqueous dispersion
protocols for nanomaterials in aqueous media (Hartmann et al.,2015) analysed which aspects of dispersion procedures could be
harmonised.4. Testing performed and test methods applied
Below, the testing performed and the method(s) applied to each
nanomaterial and endpoint are described, and this information is
presented according to the end-point groups (B to E) in Table 2.4.1. Tests performed and methods applied to physicalechemical
properties and material characterization (Group B)
Table 3 gives an overview of the physical-chemical testing and
techniques applied for each end-point andmaterial, as indicated for
example in Singh et al. (2013, 2014) and Rasmussen et al. (2013).
Analysing the information available for the nanomaterial groups,
the following preliminary observations and conclusions weremade
(data analysis is still on-going):4.1.1. Some observations relevant to nanomaterials investigated
 Four groups of materials were investigated: pure metal (gold
and silver), metal oxides (TiO2, SiO2, CeO2 and ZnO), inorganic
carbon-based nanomaterials (fullerenes, SWCNTs andMWCNTs)
and others (dendrimers and nanoclays).
 Gold and silver are provided in a liquid suspension, and so
dustiness and pour density are not relevant.
 SWCNTs and MWCNTs may have a high aspect ratio and may be
entangled, and application of techniques that measure hydro-
dynamic size did not lead to meaningful size distribution
determinations.
Table 3
Group B. Physicalechemical Properties andMaterial Characterization and associatedmeasurement techniques* used for testing the Nanomaterials based on information in the
dossiers.
Physicalechemical properties and material
characterization
Methods* used in the testing
programme
Applied to nanomaterial
C60 SW
CNT
MW
CNT
Ag Au TiO2 CeO213 ZnO12 SiO214 Dendrimers Nanoclay
10. Agglomeration/aggregation SAXS/USAXS x x
DLS x x x x x x x
TEM x x x x x x x x
SEM x x x x x
UVevis x x
DOSY NMR x
CLS x x x x
Turbidity x x x
Other ISO
9276-2
11. Water solubility Read-across from literature or
n/a
x x n/a x
ELS x x
OECD 105 x x
Turbidity x x x
Flask method x
SDR x x
12. Crystalline phase XRD x x x x x x x
Raman x x
TEM x x x
Other DSC,
POM
13. Dustiness n/
a
n/a n/a
EN 15051 x x
Modiﬁed EN 15051 x x
Vortex shaker method x x x x x
14. Crystallite size n/a
XRD x x x x x
SAXS/USAXS x x
TEM x x x x
OECD TG 110 x
UVevis x
DLS x
15. Representative TEM picture(s) TEM x x x x x x x x x x
HREM x
16. Particle size distribution DLS x x x x x x x x x
SEM x x x x x
TEM x x x x x x
AFM x x
DOSY NMR x
ISO 10808 x
SMPS x x x x
CLS x x x x x
17. Speciﬁc surface area BET
ISO 9277, 2010
x x x x x x x x x
SAXS x x
(VSSA) TEM tomography x
18. Zeta potential (surface charge) Electrophoretic mobility
method
x x x
ELS x
Zetasizer DLS x x x
Ultrasonic spectroscopy x
Doppler microelectrophoresis x x x
19. Surface chemistry (where appropriate) n/a n/a
ICP-OES x
SEM EDX x
XPS x x x x x
Other EDS,
RBA
ToF-
SIMS
DTA,
TGA
EDX
20. Photo-catalytic activity n/a
ISO 22197-1/JIS R 170-1 x x x
UVevis x x x
EPR x
KI test x x
21. Pour density n/
a
n/a n/a
JIS K 6219-2, 2006 x
ASTM D 1513-05 x x
BET x
(continued on next page)
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Table 3 (continued )
Physicalechemical properties and material
characterization
Methods* used in the testing
programme
Applied to nanomaterial
C60 SW
CNT
MW
CNT
Ag Au TiO2 CeO213 ZnO12 SiO214 Dendrimers Nanoclay
Tapped density x x
Weighing x
22. Porosity n/a Lit.
BHJ x x
BET x x x x
ISO 15901-1 x x x
23. Octanol-water partition coefﬁcient, where
relevant
Lit. n/a n/a n/a n/a n/a n/a Lit.
Other Flask
Meth.
TG 107,
TG 117
24. Redox potential SDR x x
ORP, Cyclic voltametry x x
25. Radical formation Lit. n/a
EPR x
UVevis and KI test x x
26. Other TGA
*METHODS: please note that the methods appear under “abbreviations”. x: this test was performed with indicated method.
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measure the hydrodynamic diameter of the metal oxides, but in
general, the application of DLS to “unknown” materials is not
advised (Calzolai et al., 2011).4.1.2. Some observations regarding the end-points
 Two end-points, octanolewater partition coefﬁcient and solu-
bility in water (and other media), are not applicable to those
nanoparticles which are not readily dissolved in the liquids;
readily dissolvable nanomaterials would be assessed as tradi-
tional chemicals.4.1.3. Some observations relevant to measurement techniques
applied
 For most of the nanomaterials, Transmission Electron Micro-
scopy micrographs were made, and TEM was found to give the
best qualitative size and shape description of the materials
including evaluation of agglomeration and aggregation. A new
method was proposed (de Temmerman et al., 2012) applying
quantitative randomized acquisitions and image analysis.
 X-ray diffraction was successfully applied to the metals and
metal oxides to investigate crystallinity.
 Raman spectroscopy was successfully applied to SWCNTs and
MWCNTs to investigate crystallinity.
 The standard technique for speciﬁc surface areameasurement is
BET adsorption. In the WPMN testing programme it was applied
to 8 of the nanomaterials.
 Dustiness was assessed by two methods: the vortex shaker
method and a modiﬁed CEN standard EN 15051; these methods
gave different, and not correlated, results.
 The Zeta potential is not directly measurable and was calculated
using Henry's equation applied to the results from by various
electrophoresis measurements.
 UVevis analysis may be used to measure size of pure metals in a
liquid suspension (Ag and Au).
Crystallinity was investigated by XRD (metals and metal oxides)
and Raman spectroscopy (CNTs) and the choice of technique reﬂect
the organisation of the testing, which was in different laboratories
with different apparatus available.4.2. Tests performed and methods applied to Groups C
environmental fate and D environmental toxicology
Tables 4 and 5 give an overview of the testing performed for
environmental fate and environmental toxicology.
The nanomaterials tested are mainly metals and metal oxides
for which classical biotic degradability testing (developed for
organic chemicals) is not relevant. Biotic degradability testing was
performed with SWCNTs and MWCNTs, which are inorganic
carbon-based nanomaterials, and the conclusion was that the ma-
terials are not biodegradable. Testing of degradation products was
thus not performed.
Analysis of the data (OECD, 2014b; Kühnel and Nickel, 2014)
showed that the environmental targets tested for traditional
chemicals were applicable to nanomaterials, as were the endpoints
examined for each organism or fate protocol. One exception to this
conclusion, given the current state of knowledge on nanomaterial
fate and effects, is that more work may be needed in the area of
nanomaterial biokinetics due to differences in nanomaterial uptake
and distribution compared to traditional chemicals.
Some important principles identiﬁed were:
* the need for characterization of the physicalechemical proper-
ties of nanomaterials (OECD, 2012b).
* due to differences in nanomaterial fate and exposures compared
with traditional chemicals, a fate decision tree logic and testing
strategy on dissolution rate, agglomeration behaviour, and fate
testing are needed covering water, soil and sediment and
establishing a tiered scheme to target appropriate fate and
ecotoxicity tests.
* the same method for preparing stock suspensions should be
applied to all tests allowing an easier comparison of data when
performing ecotoxicity and bioaccumulation tests.
* the best spiking (wet or dry) procedure for ecotoxicity testing of
nanomaterials is still not clear.
* to promote the comparability of results of ecotoxicity and fate
tests, the same test conditions should be used, e.g. parameters of
the suspension and test media.
* since the most appropriate dose metrics may not be known for
environmental receptors and/or anchoring to mass-based dose
metrics is still needed, the ability to interconvert doses from
mass to particle counts to surface area is essential (OECD,
2012b).
In addition to the cross-cutting conclusions above, the
Table 4
Overview of methods applied for the tests performed for Environmental fate end-points. (Nanoclays are not listed as no data was provided by June 2014).
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OECD test guidelines should be supported by additional guidance,
and other OECD test guidelines were considered inappropriate for
nanomaterials. Section 5 addresses both agreed and proposed
changes to the test guidelines and guidance documents for
nanomaterials.
Speciﬁc research needs were also identiﬁed: for aquatic eco-
toxicity, there is a need to determine possible interferences with
nanomaterials and test assay components, effects of pristine versus
altered nanomaterials; for soils and sediments, better under-
standing of the bioavailable fractions of nanomaterials, spiking
techniques, and the applicability of TGs to novel environmental
receptors is needed; and for environmental fate and behaviour,
dispersion/dissolution/transformation in environmental media,
and use of different soil types need further investigation.4.3. Testing performed and applied methods for Group E,
mammalian toxicology
An overview of the tests performed for mammalian toxicology
end-points is presented in Table 6. For inhalation toxicity testing,
the conclusions were to update the OECD test guidelines and the
“Preliminary Guidance Notes on Sample Preparation and Dosim-
etry” for which the update is now published (OECD, 2012b). Furtherrecommendations included considerations on how to generate test
atmospheres for nanomaterials depending on the use of the
toxicity tests. While inhalation toxicity tests with aggregates or
agglomerates of nano-sized particles seem adequate for hazard and
risk assessment for the handling of powders, it may be relevant for
hazard and risk assessment of nanoparticles in the production
phase to include inhalation toxicity of aerosols consisting of single
nanoparticles. Care should be taken to correct for the fact that at
high mass concentrations, size distributions will shift towards
larger particles due to agglomeration as a function of time and
particle number concentrations. As already noted, the dose metrics
needs to be carefully considered.
For testing genotoxicity of manufactured nanomaterials, seven
consensus statements were agreed on and are shown below in box
2. Table 9 lists the OECD test guidelines proposed for updating in
this context.
It was furthermore decided to carry out an interlaboratory
testing campaign to evaluate and improve the micronucleus assay
in the context of the WNT.4.4. In vitro testing performed and assays applied
In vitro assays were efﬁcient for screening of nanomaterials (Nel
et al., 2013), although, because of sedimentation effects
Table 5
Overview of methods applied for the tests performed for Environmental toxicology end-points (Nanoclays are not listed as No data was provided by June 2014).
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adjusted to account for nanomaterial transport, the dose response
relationships cannot easily be used to derive no effect levels.
C60 fullerenes, SWCNTs andMWCNTswere investigated for their
potential genotoxic hazard in vitro and in vivo. In addition to the
Japanese Guidelines, the in vitroTG 471 (Bacterial ReverseMutation
Test) and TG 473 (In Vitro Mammalian Chromosome Aberration
Test) were applied to carbonaceous nanoparticles. Also the in vivo
TG 474 (Mammalian Erythrocyte Micronucleus Test) and various
forms of the Comet assay were performed.
Although mutation frequencies and chromosomal aberrations
were not detectable in vitro using TG 471 (please note the recom-
mendations in Box 2) and TG 473, respectively, there are some in-
dications of DNA damage on lung hamster ﬁbroblasts (V79) when
using the Comet assay with some types of SWCNT and MWCNT.
Interestingly, the DNA damaging properties of a few CNT were
conﬁrmed in vivo on target tissue cells.
Using the In Vitro Mammalian Cell Gene Mutation Test (TG 476)
two MWCNT investigated did not demonstrate mutagenic activity
in L5178Y mouse lymphoma cells, although one MWCNT showed
signiﬁcant numerical chromosomal aberrations (TG 473) and
induced micronucleus formation in CHL/IU cells (In Vitro
Mammalian Cell Micronucleus Test; TG 487).
These results conﬁrmed that for risk assessment, a case-by-case
investigation of the genotoxic hazard both for a chemical entity and
for each type of nano-object (such as particles, ﬁbres, rods andclusters) is needed.
The combined in vitro and in vivo results and the scientiﬁc
knowledge of physical-chemical behaviour nanomaterials led to a
proposal for an integrated testing strategy, currently under
development.
5. Amendments to the OECD test guidelines and guidance
documents for nanomaterials
An important issue when integrating testing of nanomaterials in
the OECD test guidelines is to ensure that the test guidelines are as
broadly applicable as possible. For the development of the OECD
TGs the WNT identify and nominate experts from within the rele-
vant ﬁeld as well as experts in regulatory toxicology. Many nano-
materials are poorly soluble or completely insoluble in aqueous
media and have limited degradability, to address this, the before
mentioned Guidance on Sample Preparation and Dosimetry (OECD,
2012b) was published. Furthermore, it leads to new considerations
of physical-chemical characterization protocols, e.g. how to deter-
mine the most biologically relevant particle size distributions and
surface area measurements; fate protocols on how to disperse
materials realistically for testing; aquatic testing protocols where
the possible lack of stability of the suspension leads to concern
regarding stability of test concentrations and associated dose
metrics; and inhalation tests where nanomaterials may agglom-
erate in aerosols and/or prompt the need for lung burden analyses,
Table 6
Overview of methods used for the testing performed for the mammalian toxicology end-points1.
(continued on next page)
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Table 6 (continued )
Table 7
Test guidelines and guidance document proposals from the WPMN to the OECD Test Guidelines Programme.
Title Lead Country(ies) Included in the OECD
TGP work plan
Expected timing of adoption
by the OECD WNT
Amendments to the Inhalation Test Guidelines and Guidance Document to Accommodate
Nanomaterials
United States April 2014 2016
Test Guideline for Nanomaterial Removal from Wastewater United States April 2014 April 2015
Guidance Document on Aquatic (and Sediment) Toxicology Testing of Nanomaterials Canada/United States/
United Kingdom
April 2014 2016
Test Guideline on agglomeration behaviour of nanomaterials in different aquatic media Germany April 2014 2016
Guidance Document (Decision-Tree) on agglomeration and dissolution behaviour of
nanomaterials in aquatic media
Germany April 2014 2016
Test Guideline for dissolution rate of nanomaterials in the aquatic environment United States April 2014 2016
Guidance Document on Assessing the Apparent Accumulation Potential of Nanomaterial
for Test Guideline 305
United Kingdom/
Finland/Spain
April 2014 2016
Guidance Document on the Adaptation of in vitroMammalian Cell Based Genotoxicity Test
Guidelines for Testing of Manufactured Nanomaterials
European Commission April 2015 2017
Table 8
Test guidelines identiﬁed by the WPMN as relevant to revise or develop a guidance document for or a new test guideline; currently no lead country is available.
Title of test guideline/guidance document to be revised or developed
Revision of OECD TG 201 Algal Toxicity
Revision/GD development for OECD TG 312 Soil Column Leaching
New Test Guideline on Transformation of NMs
GD for Spiking of Soils and Sediments, OECD TG 315 and 317
Revision of TG 105 (Water solubility) to reﬂect that it is not applicable to nanomaterials
Update TG 106 (Adsorption/desorption) or develop new TG
New Test Guideline or Guidance Document on determination of aggregation/agglomeration status of NMs
New Test Guideline on determination of Zeta potential
New Test Guideline or Guidance Document on particle size and size distribution or update of the existing guidance.
New Test Guideline or Guidance Document on surface area (BET, metal oxides)
Review document describing what techniques/methods are available for measuring surface chemistry along with appropriate caveats, e.g. which classes of nanomaterials
are appropriate for the methods.
Update or add appendices to the Guidance Document on Sample Preparation and Dosimetry
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etc. Regarding environmental fate and toxicity testing, selected TGs
were discussed and it was found that OECD TGs 201 (algal andcyanobacteria reproduction), 202 (daphnid acute), 211 (daphnid
reproduction), 222 (earthworm reproduction), 225 (sediment
lumbriculus assay), 315 (sediment oligochaete bioaccumulation)
Box 2
Consensus statements from the OECD Expert meeting on gene-
toxicity testing for manufactured nanomaterials (OECD, 2014c).
1. The use of the Ames test (TG 471) is not a recommended
test method for the investigation of the genotoxicity of
nanomaterials. The test guidelines programme should
consider modifying the applicability domain within this
test guideline accordingly.
2. Measures of cytotoxicity based on cell proliferation that
are described in the test guidelines are appropriate for
determining the top concentration to be applied for
in vitro tests of nanomaterials. It is appropriate in some
cases to consider wider concentration spacing than the
standard √10 in order to ensure the concentration
eresponse relationship is well characterized, and at
concentrations not associated with cytotoxicity.
3. Characterisation of the materials should be undertaken
in the cell culture medium used both at the beginning of
treatment and, where methodologies exist, after treat-
ment. The intent when applying nanomaterials to a cell
culture medium is to create conditions that are compa-
rable, to the extent possible, with the biological and
physiological conditions within the in vivo system.
4. The extent of cellular uptake is a critical factor to consider
when interpreting test results. In some circumstances, a
lack of uptake in a mammalian cell may indicate a low
intrinsic hazard from a direct genotoxicity perspective.
5. The test guidelines program should consider modifica-
tion of the in vitro micronucleus assay to recommend,
where cyto B is used, its addition using a post-treatment
or delayed co-treatment protocol, in order to ensure a
period of exposure of the cell culture system to the
nanomaterial in the absence of cyto B.
6. Prior to conducting an in vivo genotoxicity study, there is
a need to conduct some toxicokinetic investigations to
determine if the nanomaterial reaches the target tissue,
where the target tissue is not the site of contact. In the
absence of data to the contrary, the test is not applicable
for detecting primary genotoxicity if the nanomaterial
does not reach the target tissue.
7. There are insufficient data to recommend one route of
administration over another. The basis for selecting the
route of administration for testing should be to consider
the route most applicable to human exposure(s).
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applicable to nanomaterials. However, some of them may need
adaptation (e.g. to avoid possible nanomaterial interference with
biomass quantiﬁcation in TG 201). In addition, new environmental
TGs, and new GDs for ecotoxicity and fate testing were proposed
that address some of the adaptations needed: Tables 7 and 8 give anTable 9
Needed developments for genotoxicity testing of nanomaterials: Test guidelines, guidan
Title of test guideline/guidance document to be revised or developed
Development of reporting requirements for manufactured nanomaterials genotoxicity
test media
Guidance on Toxicokinetic investigations needed prior to in vivo studies to determine
Modiﬁcations of TG 473 Chromosomal Aberration Test to accommodate manufactured
Modiﬁcations of TG 487 (In vitro Micronucleus Test to accommodate manufactured na
Review of generic well established modiﬁcations for Genotoxicity TGs for accommodaoverview. The ecotoxicity and fate GDs will rely in part on two
proposed new fate TGs: a TG on agglomeration behaviour of
nanomaterials in different aquatic media; and a TG for dissolution
rate of nanomaterials in the aquatic environment.
The test for bioconcentration of traditional chemicals in ﬁsh (TG
305) is not appropriate for nanomaterials due to the partitioning of
most nanomaterials in environmental media; and a new GD needs
to be developed (Table 7). Two test guidelines, TG 105, water sol-
ubility, and TG 106, adsorption-desorption, were not recommended
for nanomaterials. It was proposed that a new nano-speciﬁc test
guideline or an update of TG 106 on adsorption/desorption on soils
be developed (Table 8). As nanomaterials do not sorb to sludge
according to the same equilibrium kinetics that apply to traditional
chemicals, TG 303A “Aerobic Sewage Treatment Simulation Test” is
expected to be inadequate for nanomaterials as is the U.S. EPA
OPPTS 835.1110 “Activated Sludge Sorption Isotherm”, but simple
adjustments to this protocol may provide the needed data
(Westerhoff et al., 2011; Kiser et al., 2009). While the TG 303A
protocol could be used for determining nanomaterial removal
during wastewater treatment, the TG 303A guideline is focused on
biodegradation processes which may not be applicable to most
classes of nanomaterials. Determination of sorption is critical to
assessing amounts of nanomaterials released to surface waters, and
to soils and sediments (Kiser et al., 2009, 2010, 2012; Pan and Xing,
2008). Other guidelines that might need additional guidance are TG
312 on leaching from soils and TGs 315 and 317 on sediment
accumulation.
There is a need to determine a standardized protocol for pre-
dicting dissolution rates relevant for predicting the bioavailability,
reactivity, toxicity, and fate of nanomaterials such as metals, and a
proposed new TG aims to develop a protocol to determine
agglomeration behaviour of nanomaterials in different aquatic
media that vary by media type, natural organic matter concentra-
tion, degree of agitation, etc. and provide data on dispersion sta-
bility. The proposal for a GD on Aquatic (and Sediment) Toxicology
Testing of Nanomaterials recognizes that current toxicity guidelines
may need adjustments when applied to particulate and colloidal
nanomaterials andwill address the need to adequately produce and
characterize test media containing nanomaterials both for gener-
ation of stock media and exposure media, and provide guidance on
data analysis and reporting, with considerations for dosimetry, etc.
A group of experts on inhalation toxicology provided a proposal
to the WNT to amend the inhalation toxicity test guidelines and
guidance documents for nanomaterials. Recommendations for high
priority changes included the lowering of the upper cut-off of the
size range for materials to be tested, the measurement of lung
burdens where feasible, the addition of speciﬁc post-dosing
observation periods, and the recording of speciﬁc bronchoalveolar
lavage parameters. Other recommendations for incorporation into
guidance included the evaluation of additional lung biomarkers,
gathering of additional biokinetics data, and evaluation of effects
on distal organs beyond the lungs. These amendments are driven
by the need to assess effects of nanomaterials as a result of depo-
sition and retention in the deep lung. As seen from Table 7, thece documents or other documents identiﬁed by the WPMN.
TGs: Characterization of manufactured nanomaterials in as-produced state, and in
if target tissues are exposed and cellular uptake.
nanomaterials
nomaterials)
ting manufactured nanomaterials
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guidelines for Inhalation Toxicity, and a related guidance document
which takes into account nanomaterial aspects.
As for genotoxicity testing, the in vitro and in vivomicronucleus
assays, the in vitro mammalian gene mutation assays, and the
in vitro and in vivo Comet assays are promising candidates to be
adapted to enable hazard identiﬁcation of nanomaterials within the
next few years (Gonzalez et al., 2011; Doak et al., 2012; Pfuhler
et al., 2013). In contrast to the genotoxicity testing of soluble
chemicals, the type of dispersions of particles and ﬁbres as test
items may determine the uptake of particulate material, including
agglomerates, in vitro and in vivo by the test organisms. Thus, a
thorough quantitation of deposited dose on and into cells in vitro
and of organ dose in vivomay result inmore accurate dose response
relationships needed for hazard characterisation (DeLoid et al.,
2014; Hinderliter et al., 2010; Cohen et al., 2014). Consequently,
false negative results will be less likely.
Recently it has been repeatedly shown that potential incorpo-
ration of nanomaterials and adverse cellular effects are dependent
on particle dose, size and intracellular solubility (Gliga et al., 2014;
Semisch et al., 2014; Shang et al., 2014; Tavares et al., 2014). Hence
when testing the hazard potential of nanomaterials in the future,
the investigation of kinetic processes in vitro and in vivo toxicity
testing clearly needs to be addressed in more depth.
For the dermal exposure route, concerns were raised regarding
the adequacy of the test guidelines on dermal absorption TGs 427
and 428, especially relating to the observation time points.
OECD TG 417 on Toxicokinetics was found inappropriate for
assessing the organ distribution of inhaled nanomaterials as it was
designed primarily for the oral exposure route and for traditional
chemicals whose kinetics are mainly governed by diffusion/perfu-
sion and metabolic processes rather than for particulate nano-
materials whose behaviour in terms of absorption, distribution and
elimination (ADE) in the test organisms may be fundamentally
different.
The development of a new TG speciﬁcally tailored for the
inhalation route, including adequate consideration attention to the
possible ADE particularities of nanomaterials was recommended.
Currently, it is proposed to amend the test guidelines for short
term, acute, subchronic and chronic inhalation toxicity testing with
appropriate procedures for sample preparation (Creutzenberg,
2012; OECD, 2012b). The integration of extended post observation
periods in inhalation toxicity testing combined with organ burden
investigations (Krystek et al., 2014) may facilitate the estimation of
elimination half-lives of nanomaterials and may help to decide
whether the nanoscale test item is persistent and potentially bio-
accumulative in the body (Geraets et al., 2014). Upon inhalation,
low levels of primary nanoparticles have been shown to become
systemically available depending on size, shape, speciﬁc surface
area, and de-agglomeration potential in the lung (Balasubramanian
et al., 2013; Mercer et al., 2013; Moreno-Horn and Gebel, 2014).
As a last step, the WPMN has looked into how results of testing
and other information generating means could be integrated in
relevant testing strategies and assessment approaches based on
grouping and read across principles to optimise the use of infor-
mation and minimise the need of testing (in particular in vivo); this
work is still on-going.
At the beginning of its work the WPMN performed a review of
the applicability of the OECD test guidelines to nanomaterials
resulting in the publication of The WPMN the Preliminary Review
of OECD Test Guidelines for their Applicability to Manufactured
Nanomaterials (OECD, 2009). The outcomes of the WPMN work
illustrated that for the end-points investigated, the OECD test
guidelines can to a large extent be applied to nanomaterials,
however, a number of the TGs are being optimised and adapted fornanomaterials, and Tables 7e9 present an overview of work under
way. The collaboration between WPMN and the OECD test guide-
lines programmes will allow continued modiﬁcation/development
of new OECD test guidelines and guidance documents speciﬁcally
for nanomaterials.
6. Discussion and conclusions
As the WPMN Programme was designed nine years ago, the
information that it initially set out to collect and the questions that
it hoped to answer have also developed with time. In parallel with
the WPMN Testing and Assessment Programme, additional nano-
material related research results from academia and industry have
been made available in the scientiﬁc literature, and the under-
standing of nanomaterials is maturing. In addition, the sponsors
organised the actual testing by setting up national and interna-
tional research projects, thus promoting a global research effort,
however making the feed-back to the WPMN cumbersome, as for
example intellectual property rights had to be safeguarded.
In 2013, based on outcomes of the WPMN testing programme
and the parallel advances in scientiﬁc understanding of nano-
materials outside the WPMN, the OECD and its member countries
came to the conclusion that the approaches for the testing and
assessment of traditional chemicals are in general appropriate for
assessing the safety of nanomaterials (OECD, 2009), but may have
to be adapted to the speciﬁcities of nanomaterials. This was
endorsed by the OECD Council through a Recommendation (OECD,
2013). OECD Council Decisions (on the Mutual Acceptance of Data)
are legally binding on OECD member countries, the European
Commission and those other non-OECD countries which have
adhered to them (there are currently six). In essence, this system
means that data collected as part of a regulatory risk assessment of
a chemical in one countrymust be (in a legal sense) accepted in all
countries. This avoids undertaking the same test many times over
and quantiﬁable evidence has been published on the savings this
makes for governments and industry. The two provisos to this
system are that an agreed OECD Test Guideline or Guidelines have
been used and the OECD Principles of Good Laboratory Practice
have been applied during the collection of the data. The signiﬁ-
cance of the OECD nano recommendation is that it aligns nano-
materials (as chemical substances) with the legally-binding system
of Mutual Acceptance of Data, having a global impact on regulatory
management of nanomaterials, and it also opens the avenue to
providing additional global regulatory agreements on nano-
relevant guidance for regulatory testing of nanomaterials. The
majority of test guidelines are suitable already for nanomaterials
and the Mutual Acceptance of Data applies. A small number of
endpoints necessitates new nano speciﬁc test guidelines or guid-
ance, and work on new test guidelines or guidance is well under-
way as indicated for example in Tables 7 and 8
Thus, as with other chemical substances, it is clear that each
nanomaterial may pose speciﬁc challenges, but in most instances,
they can be addressed with existing test methods and assessment
approaches. In some cases, it might be necessary to adapt methods
of sample preparation and dosimetry for safety testing. Many of the
adaptations identiﬁed thus far have been triggered by the insoluble
or partially soluble nature of many nanomaterials. One area that
needs further development is the area of physical-chemical prop-
erty estimation, both in silico and testing, since some of the end-
points considered to be relevant for nanomaterials differ from
those typically considered for traditional chemicals.
Depending on the dispersion protocols used, different results
may be obtained for the end-point examined, as it is well estab-
lished that particle toxicity is not only determined by a particle's
chemical composition but also by its interactionwith the biological
K. Rasmussen et al. / Regulatory Toxicology and Pharmacology 74 (2016) 147e160 159entourage. Biophysical characterisation may therefore be required
in support of understanding of test items.
The work program is being fulﬁlled and has already generated
both data (results from the testing) and actions (guidance provided,
work initiated on TGs and other guidance documents, and addi-
tional proposals on the table waiting for concurrence). The com-
plete evaluation and extraction of conclusions continues, and
interested parties should contact the WPMN Secretariat (peter.
kearns@oecd.org mar.gonzalez@oecd.org), or work through their
member country or organizational representatives to the OECD.
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